AFC-HD AMS Life Science Co.,Ltd. [8254.T]
TOKYO, Apr 15 (Pulse News Wire) – Afc-hd AMS Life Science CO.,LTD. (8254.T) announced today that its subsidiary, Sakaya Co., Ltd., has decided to postpone the effective date of capital restructuring measures from March 31, 2026, to May 20, 2026.
The changes were originally scheduled to take effect on March 31, 2026, but delays in creditor protection procedures mandated by law necessitated the extension. The postponement includes adjustments to the capital structure involving reductions in capital stock and reserve funds, along with the transfer of surplus reserves to retained earnings. Initially planned for March 31, 2026, the new effective date is set for May 20, 2026.
Key milestones leading up to the revised effective date include: - Announcement of creditor protection procedures: April 16, 2026 - Deadline for creditors' objections: May 19, 2026 Regarding the impact on operations and dividends, the company stated that the restructuring involves internal reallocations within shareholders' equity and will not affect the net asset value. As a result, there will be no impact on performance metrics. Additionally, the resolution of deficit retained earnings due to the restructuring now allows for dividend distribution.
The company plans to implement a per-share dividend of ¥5 based on the fiscal year ending August 2026's forecasted net profit, without altering previous dividend expectations.
🟢 Confidence: High AI-translated content.